Three new acquisitions for Bodycote's Testing G...
Three New Acquisitions by Bodycote's Testing Group
Bodycote International plc, the specialist thermal processing and testing
services company, is pleased to announce the acquisitions of Saab Metech AB,
ACT Laboratories and Warrington Fire Research Group Ltd. These three
transactions for the Testing Business Unit, for which the total consideration
was £29 million in cash, advance the Group's strategy of growing its Testing
business and bring the total cash consideration spent on Testing acquisitions
during 2006 to date to £45 million.
Saab Metech AB
Bodycote has agreed to acquire the entire share capital of Saab Metech AB and
its subsidiaries, subject to regulatory approval. Saab Metech will be
integrated within the Bodycote Testing Group, and will form a new division
providing precision engineering services in the field of metrology.
Saab Metech is a well established business with a market leading position in
the Nordic Region. It is also present in Germany servicing the electronic,
defence, telecom, medical, electrical and mechanical engineering markets. The
metrology industry is experiencing a period of sustained growth as the demand
for outsourced service solutions increases. It is currently a fragmented market
offering significant consolidation opportunities. Saab Metech and Bodycote
Testing Group have significant customer synergies and the acquisition will
further enhance Bodycote's service portfolio to its customers.
ACT Laboratories
Bodycote also announces the bolt-on acquisition of the Testing & Engineering
Services division of ACT Laboratories, from ACT Holding Inc.
The acquisition of ACT Laboratories represents a major opportunity for Bodycote
to expand capabilities and capacity in the automotive testing market. There are
many synergies to exploit between the services currently offered by Bodycote's
Detroit and Mississauga facilities and those provided by ACT Laboratories.
Specialty services such as for engine cooling and exhaust system testing
enhance Bodycote's existing array of automotive services. The technical staff,
well recognised in the marketplace for their expertise and customer service,
will transfer to Bodycote and assist in the growth of the business.
The acquired business will operate as part of the Bodycote Testing Group
America's network of laboratories. ACT Laboratories, located in both Hillsdale
and Wixom, Michigan USA are A2LA accredited to the ISO 17025 standard. The
laboratories also maintain approvals from the major OEMs and Tier One
suppliers.
Warrington Fire Research Group Ltd
Lastly, Bodycote is pleased to announce the bolt-on acquisition of Warrington
Fire Research Group Ltd. including its subsidiaries and joint ventures located
in the UK, Belgium, France, Italy, Hong Kong, Dubai and Australia. Warrington
Fire is an internationally recognised centre of excellence in the area of fire
product & system testing, related consultancy, inspection and certification.
This acquisition complements Bodycote's existing Canadian fire testing centre,
bringing expertise in European fire testing standards and extending our
geographical reach.
John Hubbard, Chief Executive of Bodycote International, said:
"We are delighted to welcome Saab Metech, ACT Laboratories and Warrington Fire
to the Bodycote Group. These acquisitions further strengthen Bodycote's Testing
operations.
"Bodycote is keen to support management's aspirations to expand the Metech
company through the growing demand for outsourced service solutions together
with additional bolt on acquisitions in new geographical markets. ACT
Laboratories further strengthens our presence in the North American automotive
testing market, whilst the acquisition of Warrington Fire represents a
significant step in expanding our coverage in fire testing."
For further information, please contact:
John D. Hubbard, Chief Executive
David Landless, Finance Director
Bodycote International PLC Tel no: 01625 505300
Jon Simmons
Sally Lewis
Financial Dynamics Tel no: 020 7831 3113
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.